Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Sports Medicine CoHKSE:01609 -0.21%20 Days Payable is 70.43 as of Dec. 2025, which is 14% above its 10-year median of 61.95. GuruFocus rates HKSE:01609 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 793 Medical Devices & Instruments companies, Star Sports Medicine Co ranks better than 88.65% on this metric.
The historical rank and industry rank for Star Sports Medicine Co's Days Payable or its related term are showing as below:
HKSE:01609'
s Days Payable Range Over the Past 10 Years
Min: 50.7 Med: 61.95 Max: 277.66
Current: 277.66
During the past 4 years, Star Sports Medicine Co's highest Days Payable was 277.66. The lowest was 50.70. And the median was 61.95.
HKSE:01609's Days Payable is ranked better than 88.65% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs HKSE:01609: 277.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01609 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Star Sports Medicine Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Sports Medicine Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Star Sports Medicine Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Star Sports Medicine Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Star Sports Medicine Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Sports Medicine Co (HKSE:01609) has a Days Payable of 70.43 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Star Sports Medicine Co and its competitors. This is 14% above median its historical median of 61.95. Over the past decade, Star Sports Medicine Co's Days Payable has ranged from 50.70 to 277.66. According to the industry distribution chart, Star Sports Medicine Co ranks #90 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 11.3%.
Is Star Sports Medicine Co's Days Payable too high?
Star Sports Medicine Co's current Days Payable of 70.43 is 14% above median its 10-year median of 61.95. Over the past 10 years, this metric has ranged from a low of 50.70 to a high of 277.66. The Medical Devices & Instruments industry median Days Payable is 68.47. Star Sports Medicine Co's value of 70.43 is 2.9% above this industry median. Based on the distribution chart, Star Sports Medicine Co ranks #90 out of 793 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Star Sports Medicine Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Star Sports Medicine Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Star Sports Medicine Co ranks #90 out of 793 companies for Days Payable. This places Star Sports Medicine Co in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.47. Star Sports Medicine Co's value of 70.43 is 2.9% above this benchmark. Historically, Star Sports Medicine Co's own Days Payable has ranged from 50.70 to 277.66 over the past decade. While the company's 10-year median is 61.95 vs. the industry median of 68.47, Star Sports Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Sports Medicine Co's current Days Payable of 70.43 is 2.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Star Sports Medicine Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Sports Medicine Co's current Days Payable is 70.43, which is 14% above median its own 10-year median of 61.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Sports Medicine Co stock overvalued right now?
Star Sports Medicine Co (HKSE:01609) has a current Days Payable of 70.43. The current Days Payable is 70.43, which is 14% above median its 10-year median of 61.95 and 2.9% above the Medical Devices & Instruments industry median of 68.47. Star Sports Medicine Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Star Sports Medicine Co (HKSE:01609), the current Days Payable is 70.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
20GF Score
Get the complete analysis for HKSE:01609
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01609 has been successfully added to your 
